|
|
|
|
|
|
Sponsors and Collaborators: |
Intermountain Health Care, Inc. Deseret Foundation |
Information provided by: | Intermountain Health Care, Inc. |
ClinicalTrials.gov Identifier: | NCT00403507 |
The purpose of the study is to determine if participation in an exercise program helps memory loss from getting worse, and if it improves daily functioning and attitudes of those with probable Alzheimer's disease. It will involve participation of both the person with memory loss and someone who knows their daily activities (e.g., husband, wife, adult child, or caregiver).
Condition | Intervention | Phase |
Alzheimer Disease Memory Disorders Dementia |
Behavioral: Participation in a monitored exercise program |
Phase II |
Genetics Home Reference related topics: | Alzheimer disease |
MedlinePlus related topics: | Alzheimer's Disease Dementia Exercise and Physical Fitness Memory |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Single Blind, Active Control, Single Group Assignment, Efficacy Study |
Official Title: | Physical Activity as a Treatment of Mild-Stage Probable Alzheimer's Disease |
Estimated Enrollment: | 79 |
Study Start Date: | October 2006 |
Estimated Study Completion Date: | July 2008 |
Currently, there is no cure for the memory loss associated with Alzheimer's disease, though some medications can help it from getting worse. The research study will help to answer the question if participation in an exercise program helps memory loss from getting worse, and if it improves daily functioning and attitudes of those with probable Alzheimer's disease. It will involve participation of both the person with memory loss and someone who knows their daily activities.
The research study is a randomized-control trial: some participants will be picked to participate in the exercise program, while others will not. Their memory, thinking abilities, activities, and attitudes will be measured at baseline and follow-up assessment 5-6 months later. Participants are in good health, and are treated with a cholinesterase inhibitor for memory loss (standard treatment).
Ages Eligible for Study: | 65 Years to 89 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Kelly Garrett, Ph.D. | 801-408-5498 | KellyDavisGarrett@intermountainmail.org |
Contact: Cherie P Brunker, M.D. | 801-408-8600 |
United States, Utah | |||||
LDS Hospital | Recruiting | ||||
Salt Lake City, Utah, United States, 84143 | |||||
Contact: Kelly Garrett, Ph.D. 801-408-5498 KellyDavisGarrett@intermountainmail.org | |||||
Contact: Cherie P Brunker, M.D. 801-408-8600 | |||||
Principal Investigator: Kelly Garrett, Ph.D. |
Intermountain Health Care, Inc. |
Deseret Foundation |
Principal Investigator: | Kelly Garrett, Ph.D. | Intermountain Health Care- LDS Hosptial |
Answers to questions about participation in research study, and screening form for prospective participants to complete with their health care provider. 
  |
Study ID Numbers: | Kelly Garrett |
First Received: | November 21, 2006 |
Last Updated: | May 12, 2008 |
ClinicalTrials.gov Identifier: | NCT00403507 |
Health Authority: | United States: Institutional Review Board |
|
|
|
|
|